Glucagon-like peptide-1 receptor agonists as adjunctive therapy in refractory hypertriglyceridemia following recurrent pancreatitis.

Miura D, Nicholls S, Joham AE, Braude M, Tay CT

Open source

DOI
10.1210/jcemcr/luag274
Published
2026 Oct
Container
JCEM case reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1210/jcemcr/luag274,
  title = {Glucagon-like peptide-1 receptor agonists as adjunctive therapy in refractory hypertriglyceridemia following recurrent pancreatitis.},
  author = {Miura D and Nicholls S and Joham AE and Braude M and Tay CT},
  year = {2026},
  journal = {JCEM case reports},
  doi = {10.1210/jcemcr/luag274},
  url = {https://doi.org/10.1210/jcemcr/luag274}
}

RIS

TY  - JOUR
TI  - Glucagon-like peptide-1 receptor agonists as adjunctive therapy in refractory hypertriglyceridemia following recurrent pancreatitis.
AU  - Miura D
AU  - Nicholls S
AU  - Joham AE
AU  - Braude M
AU  - Tay CT
PY  - 2026
JO  - JCEM case reports
DO  - 10.1210/jcemcr/luag274
UR  - https://doi.org/10.1210/jcemcr/luag274
ER  - 

APA

D, M., S, N., AE, J., M, B., & CT, T. (2026). Glucagon-like peptide-1 receptor agonists as adjunctive therapy in refractory hypertriglyceridemia following recurrent pancreatitis.. JCEM case reports. https://doi.org/10.1210/jcemcr/luag274

Source records